29 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
before the FDA accepts it for filing. Once an NDA is accepted for filing, the FDA begins an in-depth review of the application. Pursuant to goals … and Non-Equity Incentive Plan Compensation.
We seek to motivate and reward our executives for achievements relative to our corporate goals
8-K
EX-10.1
MBRX
Moleculin Biotech Inc
5 Jan 24
Departure of Directors or Certain Officers
5:14pm
(or the Board, if such committee has not been formed or has been dissolved), based on goals and objectives approved by the Compensation Committee of the Board
8-K
EX-10.2
v6cynibcvk
5 Jan 24
Departure of Directors or Certain Officers
5:14pm
8-K
EX-10.3
mmd3h4seqzeb5i
5 Jan 24
Departure of Directors or Certain Officers
5:14pm
S-8
EX-4.5
5ndq5 y6zf
21 Jun 23
Registration of securities for employees
5:16pm
S-8
EX-4.5
n80 oj12hyrdgs68
19 Jul 22
Registration of securities for employees
5:18pm
8-K
EX-10.1
yib5 h31269t8c04o
21 Jun 21
Entry into a Material Definitive Agreement
4:17pm
8-K
gnlcqf00
26 Aug 20
Departure of Directors or Certain Officers
4:12pm
S-8
EX-4.4
ce1bca 0k9
21 Aug 20
Registration of securities for employees
4:31pm
8-K
EX-99.1
wi0ibi3n50w1hq930ig
27 May 20
Moleculin Provides Update on Coronavirus Drug Development
5:20pm